Cycle and Catalent

Cycle and Catalent, Inc. (NYSE: CTLT) have partnered to develop 4 products that will each use Catalent’s Zydis® oral disintegrating tablet (ODT) and Zydis Ultra® technologies.

Read the press release here.

Cycle and Medherant

Cycle and Medherant Ltd (a spin-out company from the University of Warwick, UK) have partnered to develop products that will each use Medherant’s TEPI Patch® transdermal patch technology.

Read the press release here.

Zydis® and Zydis Ultra® are registered trademarks of R.P. Scherer Technologies, Inc., a wholly owned subsidiary of Catalent, Inc. TEPI Patch® is a registered trademark of Medherant Limited.

TECHNOLOGY PARTNERSHIPS
GET IN TOUCH

Contact us to discuss delivering best-in-class products together to treat genetic metabolic disorders and neurological conditions.

Contact us today
ABOUT US
PIPELINE